ArticleNeuro-oncology advances

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Shuodan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.